TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.850
+0.050 (1.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
TELA Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for TELA Bio stock have an average target of 9.25, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 224.56% from the current stock price of 2.85.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 8, 2024.
Analyst Ratings
The average analyst rating for TELA Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +75.44% | Nov 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +321.05% | Oct 4, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +321.05% | Aug 13, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +180.70% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +180.70% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
76.21M
from 58.45M
Increased by 30.39%
Revenue Next Year
95.66M
from 76.21M
Increased by 25.51%
EPS This Year
-1.38
from -2.04
EPS Next Year
-0.66
from -1.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 79.3M | 99.2M | 126.5M | ||
| Avg | 76.2M | 95.7M | 119.0M | ||
| Low | 73.0M | 90.9M | 110.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 35.6% | 30.2% | 32.2% | ||
| Avg | 30.4% | 25.5% | 24.4% | ||
| Low | 24.9% | 19.3% | 15.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.35 | -0.47 | -0.01 | ||
| Avg | -1.38 | -0.66 | -0.25 | ||
| Low | -1.42 | -0.86 | -0.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.